Medical cannabis

Medical cannabis – the evolving law and innovation in treatment

The developing legal approach in the UK to medical cannabis highlights the problems law makers have in responding adequately to clinical and technological advances: especially those that challenge conventional views. This has arguably stifled innovation in medical cannabis research in the UK, and prevented patients from receiving worthwhile treatments. This

Share our insights
Continue reading

Regulating disruptive technology – are you an activist or a sceptic?

In his interview with the FT, published earlier this week, Jochen Homann, president of Germany’s Bundesnetzagentur or Federal Networks Authority, underlines his determination that US tech giants, such as Google and Facebook (and their services, such as Gmail and WhatsApp), should be regulated like conventional telecoms firms.  As he puts

Share our insights
Continue reading